Lee Roth | Investor Relations |
Dror Harats | Chief Executive Officer |
Amos Ron | Chief Financial Officer |
Kevin DeGeeter | Oppenheimer |
Arthur He | H.C. Wainwright |
Thank you, Sheryl. Good morning, and thank you joining today’s VBL Therapeutics First Quarter 2021 Financial Results and Corporate Update Conference Call. Leading the call this morning will be Prof. Dror Harats, Chief Executive Officer; and Amos Ron, Chief Financial Officer. A press release with the company’s financial results was issued earlier this morning and as available on the Investor Relations page of the company’s website at vblrx.com.